CYP2B6
cytochrome P450, family 2, subfamily B, polypeptide 6 | |
---|---|
Identifiers | |
Symbol | CYP2B6 |
Entrez | 1555 |
HUGO | 2615 |
OMIM | 123930 |
RefSeq | NM_000767 |
UniProt | P20813 |
Other data | |
Locus | Chr. 19 q13.2 |
WikiDoc Resources for CYP2B6 |
Articles |
---|
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on CYP2B6 at Clinical Trials.gov Clinical Trials on CYP2B6 at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on CYP2B6
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating CYP2B6 Risk calculators and risk factors for CYP2B6
|
Healthcare Provider Resources |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
CYP2B6 is a member of the Cytochrome P450 group of enzymes. Along with CYP2A6, it is involved with metabolizing nicotine, along with many other substances.
CYP2B6 Ligands
External links
- CYP2B6 at the US National Library of Medicine Medical Subject Headings (MeSH)
Template:WH Template:WikiDoc Sources
- ↑ 1.0 1.1 Mentioned both in the reference named FASS and were previously mentioned in Wikipedia. Further contributions may follow other systems
- ↑ Swedish environmental classification of pharmaceuticals Facts for prescribers (Fakta för förskrivare)